Approval · Notice of Compliance 8717 · 2007
MULTIHANCE: Notice of Compliance 8717
Issued April 18, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8717
- Date
- April 18, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: magnetic resonance angiography (mra)
- Therapeutic class
- Diagnostic contrast agent for mri and mra
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MULTIHANCE | Not yet assigned | — |
Medicinal ingredients
- GADOBENATE DIMEGLUMINE 529 MG per ML